2021-2022 University of Chicago Inflammatory Bowel Disease Preceptorship

Inflammatory bowel diseases (IBD), Crohn’s disease, and ulcerative colitis afflict between 1.6 and 3 million Americans, with 30,000 new cases diagnosed each year. Recently, the clinical community has had an increased appreciation of the importance experience plays in the treatment of inflammatory bowel disease. New therapies, an explosion of research, and advances in the field have made the effective management of the IBD patient more complicated than ever. Issues such as optimal therapy selection, modification of disease natural history with improvement of long-term outcomes, and improvements in quality of care make the appropriate and effective management of patients with Crohn's disease and ulcerative colitis a complex and expanding area of education and training. Busy clinicians cannot possibly stay updated on all key developments that can lead to improved patient outcomes.
 
The goal of this program is to advance clinical practice in the treatment of IBD patients.
 

Please note: the CME accredited portion of this program is part of the 2021-2022 IBD Preceptorship Program, which consists of three phases. The self-study component of this program can only be completed as part of the full program.

The 2021-2022 IBD Preceptorship Program consists of:

  1. One month self-study (CME-accredited) 
  2. One month virtual preceptorship consisting of Zoom meeting attendance at the University of Chicago Medicine IBD Center’s research in progress meetings, multidisciplinary conferences, and case discussion roundtables, and mentoring meetings with faculty. Note: some of these activities are also certified for CME credit.
  3. Two day on site, in person clinical observership at the University of Chicago Medicine IBD Center, after COVID-related visitor restrictions have lifted, consisting of clinic observations, inpatient rounding, and/or procedures with IBD faculty. All related travel expenses, meals, and lodging will be reimbursed.


Medium
Series of journal articles with self-reflection questions
 
Activity Length
Reading, Self-Reflection, and Evaluation: 8 hour and 15 minutes

 
Commercial Support: Educational grant funding has been generously provided by AbbVie, Inc.

Target Audience

This activity is designed for physicians and other healthcare professionals dedicated to the treatment of patients with inflammatory bowel diseases.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Recall the latest developments in IBD research;
  • Describe key concepts, evidence-based practice, and diagnosis techniques found in IBD research;
  • Evaluate treatment options for complicated patient cases in both clinical and hospital settings;
  • Explain the latest advances in diagnostic and therapeutic options for IBD;
  • Identify gaps in practice in the treatment of patients with IBD;
  • Discuss steps to close those practice gaps.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
For more information, please contact:
CME Coordinator Contact Name: 
Anna Gomberg
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
773-702-6073
AttachmentSize
PDF icon Activity Flyer916.56 KB
Summary
Available credit: 
  • 8.25 AMA PRA Category 1 Credit™
  • 8.25 Participation
Activity opens: 
04/30/2021
Activity expires: 
08/01/2022
UNIVERSITY OF CHICAGO COURSE LEADERSHIP
  Professor of Medicine
  Director, Inflammatory Bowel Disease Center
  Co-Director, Advanced IBD Fellowship Program


  Sushila Dalal, MD
  Assistant Profressor of Medicine




  Joel Pekow, MD
  Associate Professor of Medicine




  David T. Rubin, MD
  Joseph B. Kirsner Professor of Medicine
  Chief, Section of Gastroenterology, Hepatology and Nutrition
  Co-Director, Digestive Diseases Center


  Atsushi Sakuraba, MD, PhD
  Associate Professor of Medicine



 
  Anna Gomberg
  Administrative Director, University of Chicago Medicine IBD Center

 

 


Selected Publications & Additional Resources
View a partial list of Dr. Cohen's, Dr. Dalal's, Dr. Pekow's, Dr. Rubin's, and Dr. Sakuraba's publications through the National Library of Medicine's PubMed online database.

Additional references for further study can be found in the journal articles.
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Disclosures
Russell D. Cohen, MD has served as a consultant and advisor for Abbvie Laboratories, BMS/ Celgene, Eli Lilly, Genentech, Gilead Sciences, Hoffmann La-Roche, Janssen, Pfizer, Takeda, and UCB Pharma. Dr. Cohen has received grant funding from Abbvie, BMS/Celgene, Boehringer Ingelheim, Genentech, Gilead Sciences, Hollister, Medimmune, Mesoblast Ltd., Osiris Therpeutics, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, Schwarz Pharma, Seres Therapeutics, Takeda Pharma, and UCB Pharma.

Sushila Dalal, MD has served on the speaker’s bureau for AbbVie and as a consultant for Pfizer.

Joel Pekow, MD has served on the advisory board of Takeda and as a consultant for Genetech and Verastem.

David T. Rubin, MD has served as a consultant for Abbvie, Altrubio, Allergan, Inc., Arena Pharmaceuticals, Athos Therapeutics, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Ltd., Bristol-Myers Squibb, Celgene Corp/Syneos, GalenPharma/Atlantica, Genentech/Roche, Gilead Sciences, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Materia Prima, Pfizer, Prometheus Biosciences, Reistone, and Takeda

Atsushi Sakuraba, MD, PhD, Anna Gomberg, and the staff of the Center for Continuing Medical Education have no relevant financial relationships with ineligible companies to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated.

Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
REGISTRATION
Applications for the program are now open! Space is limited, so click the button below to submit yours today!
 
 
INSTRUCTIONS FOR PARTICIPATION AND CLAIMING CREDIT
This online educational activity (enduring material) is designed to be completed within the time designated. To successfully earn credit, participants must complete the activity during the valid credit period. To receive a certificate, the participant must read the required articles and successfully complete the required self-reflections. The IBD Center will send the articles and self-reflection instructions to all participants. Upon successful completion, the participant may claim credit and save or print their certificate.
 
Physicians are eligible to receive continuing education credit applicable to their profession. All other participants will receive a certificate indicating participation in this AMA PRA Category 1 Credit™-approved activity. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
 
For questions about CME credit or technical issues, please contact the Center for CME at The University of Chicago at cme@bsd.uchicago.edu.


DISCLAIMER
The information presented in this activity is for continuing medical education purposes only. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the University of Chicago Pritzker School of Medicine, the University of Chicago Medicine, or the Department/Section.

Please login or create an account to proceed.